HomeInsightsPE

Lincoln Pharmaceuticals Ltd PE Ratio

Lincoln Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

10.2 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

PE

19.5

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Lincoln Pharmaceuticals Ltd is 19.5 as of 11 Dec 9.00 AM .
  • The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 8.7 on March 2019 to 12.6 on March 2024 . This represents a CAGR of 6.37% over 6 years.
  • The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 942.2 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Lincoln Pharmaceuticals Ltd

No data available

Company Fundamentals for Lincoln Pharmaceuticals Ltd

No data available

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

Share Price

₹ 942.2

0.80 (0.08%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Lincoln Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Lincoln Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024942.2
10 Dec 2024941.4
09 Dec 2024957.35
06 Dec 2024919.9
05 Dec 2024923.25
04 Dec 2024904.9
03 Dec 2024754.1
02 Dec 2024628.45
29 Nov 2024630.45
28 Nov 2024636.6

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lincoln Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Lincoln Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Lincoln Pharmaceuticals Ltd

No data available

* All values are in %

About Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
  • All the assets and business of the erstwhile partnership were transferred to the Company.
  • The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
  • The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
  • It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

Lincoln Pharmaceuticals Ltd News Hub

News

Lincoln Pharmaceuticals consolidated net profit rises 24.51% in the June 2024 quarter

Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended J...

Read more

2024-08-09 00:00:00

News

Lincoln Pharmaceuticals AGM scheduled

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

2024-09-03 00:00:00

News

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14...

Read more

2024-11-07 00:00:00

News

Lincoln Pharmaceuticals to conduct AGM

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

2024-09-03 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lincoln Pharmaceuticals Ltd

What is the current PE Ratio of Lincoln Pharmaceuticals Ltd?

The Current PE Ratio of Lincoln Pharmaceuticals Ltd is 19.53 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Lincoln Pharmaceuticals Ltd last year?

The PE Ratio of Lincoln Pharmaceuticals Ltd was 9.3 last year, now the PE ratio is 19.53, showing a year-on-year growth of 110.0%.

What does the PE Ratio of Lincoln Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Lincoln Pharmaceuticals Ltd is 19.53. This ratio indicates that investors are willing to pay 19.53 times the earnings per share for each share of Lincoln Pharmaceuticals Ltd.

What is the PE Ratio Growth of Lincoln Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lincoln Pharmaceuticals Ltd grew by 110.0% whereas, the EPS ratio grew by 11.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions